The American Brachytherapy Society recommendations for brachytherapy of carcinoma of the lung

Nag, Subir; Kelly, James; Horton, John L.; Komaki, R.; Nori, Dattatreyudu

doi:10.1016/s0360-3016(00)80461-7

Cited by 9 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2001 and 2003, the ABS published a series of guidelines for women wishing APBI 41,42 . The updated 2003 version 42 was previously reviewed in a workshop by the National Cancer Institute (Bethesda) Division of Cancer Treatment and Diagnosis, Radiation Research Programme 55 .…”

Section: Discussionmentioning

confidence: 99%

“…Accelerated partial breast irradiation (APBI) using a single fraction of external‐beam radiation therapy (EBRT) to the lumpectomy cavity intraoperatively, 30 or by means of a fractionated high dose rate brachytherapy (HDRB) implant, 31–40 are evolving new techniques with the potential to redefine breast cancer care. Current end results from Phase I/II studies 31–40 and a single Phase III trial 33 are encouraging, and the American Brachytherapy Society (ABS) 41,42 has recently published treatment recommendations.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Accelerated partial breast irradiation using interstitial high dose rate ¹⁹²iridium brachytherapy: Early Australian experience and review of the literature

Stevens

Cooper

Cross

et al. 2006

Australasian Radiology

View full text Add to dashboard Cite

Summary Accelerated partial breast irradiation (APBI) is an evolving new technique of adjuvant irradiation in selected women with early-stage breast cancer. We developed a pilot programme of APBI in 2000 and report end results in seven patients followed for a mean of 42.7 months (range 29-55 months). Good to excellent cosmesis and no loco-regional relapse or systemic metastases have occurred. The literature related to APBI is reviewed.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Accelerated partial breast irradiation using interstitial high dose rate ¹⁹²iridium brachytherapy: Early Australian experience and review of the literature

Stevens

Cooper

Cross

et al. 2006

Australasian Radiology

View full text Add to dashboard Cite

show abstract

“…Lowering the prescribed dose or the number of fractions as suggested by the American Brachytherapy Society recommendations [34] in situations identified as of higher risk (both clinically and by volumes evaluation) could also be an alternative to protect patients from bleeding.…”

Section: Discussionmentioning

confidence: 99%

Irradiated volume and the risk of fatal hemoptysis in patients submitted to high dose-rate endobronchial brachytherapy

et al. 2007

View full text Add to dashboard Cite

“…The results from various centers show bronchoscopy response from 59% to 100% and clinical improvement from 50% to 100%. [31] Due to the differences in patient populations and the variability in dose and fractionation employed, comparison of these results is difficult. Stenosis and Radiation bronchitis may occur after endobronchial brachytherapy, necessitating close follow-up.…”

Section: Patients With Previous Ebrt Of Sufficientmentioning

confidence: 99%

Effect of pFNA internal fixation of senile fracture in maxillofacial injuries

Shahabaz¹,

Afzal²

2021

SPR

View full text Add to dashboard Cite

A technique of radiation therapy delivery in which the radioactive sources are placed very close or even inside the target volume is called Brachytherapy (BT). Brachytherapy is a type of radiation therapy. It destroys cancer cells by making it hard for them to multiply. In this technique, a radiation source is placed directly into or near a tumour. High dose-rate brachytherapy is also known as HDR brachytherapy, or temporary brachytherapy. It is a type of internal radiotherapy. HDR was developed to reduce the risk of cancer recurrence while shortening the amount of time it takes to get radiation treatment. HDR also limits the dose of radiation (associated side effects) to surrounding normal tissue. The important benefits of HDR brachytherapy include extremely precise radiation therapy delivered internally, used alone or after surgery to help prevent cancer recurrence, convenient treatments that are usually pain-free, and a reduction in the risk of common short- and long-term side effects. Currently, tumour dose, as well as doses of the surrounding normal structures, can be evaluated accurately, and high-dose-rate brachytherapy enables three-dimensional image guidance. The biological disadvantages of high-dose-rate were overcome by fractional irradiation. In the definitive radiation therapy of cervical cancer, high-dose-rate brachytherapy is most necessary. Most patients feel little discomfort during brachytherapy. There is no residual radioactivity when the treatment is completed. A patient may be able to go home shortly after the procedure, resuming his normal activities with few restrictions. An advantage of brachytherapy is to deliver a high dose to the tumour during treatment and save the surrounding normal tissues. High-dose-rate (HDR) brachytherapy has great promise with respect to proper case selection and delivery technique because it eliminates radiation exposure, can be performed on an outpatient basis and allows short treatment times. Additionally, by varying the dwell time at each dwell position, the use of a single-stepping source allows optimization of dose distribution. As the short treatment times do not allow any time for correction of errors, and mistakes can result in harm to patients, so the treatments must be executed carefully by using HDR brachytherapy. Refinements will occur primarily in the integration of imaging (computed tomography, magnetic resonance imaging, intraoperative ultrasonography) and optimization of dose distribution and it is expected that the use of HDR brachytherapy will greatly expand over the next decade. Various factors in the development of well-controlled randomized trials addressing issues of efficacy, quality of life, toxicity and costs-versus-benefits will ultimately define the role of HDR brachytherapy in the therapeutic armamentarium. Surrounding healthy tissues are not affected by the radiation due to the ability to target radiation therapy at high dose rates directly to the tumour. Treatment to be delivered as an outpatient in as few as one to five sessions is also allowed by this targeted high dose approach. HDR brachytherapy is the most precision radiation therapy, even better than carbon ion therapy. At the time of invasive placement of the radiation source into the tumour area, brachytherapy requires the skills and techniques of radiation oncologists.

show abstract

The American Brachytherapy Society recommendations for brachytherapy of carcinoma of the lung

Cited by 9 publications

References 0 publications

Accelerated partial breast irradiation using interstitial high dose rate ¹⁹²iridium brachytherapy: Early Australian experience and review of the literature

Accelerated partial breast irradiation using interstitial high dose rate ¹⁹²iridium brachytherapy: Early Australian experience and review of the literature

Irradiated volume and the risk of fatal hemoptysis in patients submitted to high dose-rate endobronchial brachytherapy

Effect of pFNA internal fixation of senile fracture in maxillofacial injuries

Contact Info

Product

Resources

About

The American Brachytherapy Society recommendations for brachytherapy of carcinoma of the lung

Cited by 9 publications

References 0 publications

Accelerated partial breast irradiation using interstitial high dose rate 192iridium brachytherapy: Early Australian experience and review of the literature

Accelerated partial breast irradiation using interstitial high dose rate 192iridium brachytherapy: Early Australian experience and review of the literature

Irradiated volume and the risk of fatal hemoptysis in patients submitted to high dose-rate endobronchial brachytherapy

Effect of pFNA internal fixation of senile fracture in maxillofacial injuries

Contact Info

Product

Resources

About

Accelerated partial breast irradiation using interstitial high dose rate ¹⁹²iridium brachytherapy: Early Australian experience and review of the literature

Accelerated partial breast irradiation using interstitial high dose rate ¹⁹²iridium brachytherapy: Early Australian experience and review of the literature